clinical trial

In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of…

What if a common anti-depressant could help stop some angry, impulsive men from committing domestic violence? That question…

NEED TO KNOW Jaclyn Hayes Lin was 32 weeks pregnant when she was diagnosed with stage 4 pancreatic…

As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in…

Opus Genetics, Inc. Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular…

A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…

Just as a computer’s operating system can be rewritten after a major update, dengue infection can ‘re-programme’ the…

Millions may be missing early diabetes risk. AI models show why your blood sugar spikes might matter more…

Using gene therapy to treat hereditary deafness is safe and effective in both children and adults, according to…

Parkinson’s disease (PD) is a progressive and complex neurodegenerative disorder that affects movement. It is narked not only…

Lilly’s triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial